ELUCIDATING RESISTANCE MECHANISM TO PARP INHIBITORS FOR THE DEVELOPMENT OF NOVEL THERAPEUTIC APPROACHES IN HIGH-GRADE SEROUS OVARIAN CANCER

被引：1
|
作者：
Kulbe, Hagen [1 ]
Kassuhn, Wanja [2 ,3 ,4 ,5 ]
Ringel, Frauke [2 ,3 ,4 ,5 ]
Welsch, Gabriele [2 ,3 ,4 ,5 ]
Treffkorn, Peggy [2 ,3 ,4 ,5 ]
Taube, Eliane [2 ,3 ,4 ,5 ]
Horst, David [2 ,3 ,4 ,5 ]
Sehouli, Jalid [2 ,3 ,4 ,5 ]
Braicu, Elena [2 ,3 ,4 ,5 ]
机构：
[1] Charite Univ Med Berlin, Dept Gynecol, Campus Virchow Clin, Berlin, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Free Univ Berlin, Berlin, Germany
[4] Humboldt Univ, Berlin, Germany
[5] Berlin Inst Hlth, Berlin, Germany
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2020年 / 30卷
关键词：
D O I：
10.1136/ijgc-2020-ESGO.133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
416
引用
收藏
页码：A79 / A79
页数：1
相关论文
共 50 条
  • [31] The genesis and evolution of high-grade serous ovarian cancer
    David D. L. Bowtell
    Nature Reviews Cancer, 2010, 10 : 803 - 808
  • [32] Proteogenomic characterization of high-grade serous ovarian cancer
    McDermott, Jason E.
    Payne, Samuel
    Ray, Debjit
    Petyuk, Vladislav
    Moore, Ronald
    Gritsenko, Marina
    Smith, Richard
    Rodland, Karin
    CANCER RESEARCH, 2016, 76
  • [33] Cell Origins of High-Grade Serous Ovarian Cancer
    Kim, Jaeyeon
    Park, Eun Young
    Kim, Olga
    Schilder, Jeanne M.
    Coffey, Donna M.
    Cho, Chi-Heum
    Bast, Robert C., Jr.
    CANCERS, 2018, 10 (11)
  • [34] High-grade serous ovarian cancer: the clone wars
    Aleksander Salomon-Perzyński
    Magdalena Salomon-Perzyńska
    Bogdan Michalski
    Violetta Skrzypulec-Plinta
    Archives of Gynecology and Obstetrics, 2017, 295 : 569 - 576
  • [35] High-grade serous ovarian cancer: the clone wars
    Salomon-Perzynski, Aleksander
    Salomon-Perzynska, Magdalena
    Michalski, Bogdan
    Skrzypulec-Plinta, Violetta
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (03) : 569 - 576
  • [36] The role of Apela in high-grade serous ovarian cancer
    Daily, Laura R.
    Ganguly, Debolina
    Hayes, D. Neil
    Wang, Yinan
    Sims, Michelle M.
    Cheng, Jinjun
    ElNaggar, Adam C.
    Pfeffer, Lawrence M.
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Drugs Repurposing in High-Grade Serous Ovarian Cancer
    Torralba, Manuel
    Farra, Rossella
    Maddaloni, Marianna
    Grassi, Mario
    Dapas, Barbara
    Grassi, Gabriele
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (42) : 7222 - 7233
  • [38] AXL pathway as a target to overcome resistance to PARP inhibitors in high-grade serous ovarian (HGSOC) and triple-negative breast cancer (TNBC) cell lines
    Perez-Fidalgo, Jose Alejandro
    Martinez Pretel, Juan Jose
    Sanchez Serrano, Paloma
    Heredia, Victoria
    Hochstadt, Jan
    Mendiola, Marta
    Redondo, Andres
    Gonzalez Villena, Lidia
    Ruiz Linuesa, Miriam
    Pineda, Begona
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Neurotensin signaling pathway as a potential therapeutic target in high-grade serous ovarian cancer
    Norris, E. J.
    DeStephanis, D.
    Zhang, Q.
    Tait, D. L.
    Ganapathi, R.
    Ganapathi, M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 71 - 71
  • [40] Development of peritoneal carcinomatosis by multicellular structures of high-grade serous ovarian cancer
    Goyeneche, Alicia A.
    Srinivasan, Rekha
    Valdez, Juan M.
    Telleria, Carlos M.
    CANCER RESEARCH, 2015, 75
12345